Clinical Trials for Treatment-naïve High Risk Chronic Lymphocytic Leukemia

Find clinical trials for treatment-naïve high risk chronic lymphocytic leukemia. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

NCT ID: NCT04623541

This clinical trial is studying a new treatment called epcoritamab for patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or Richter's Syndrome (a type of aggressive lymphoma)....

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Philadelphia, Pennsylvania, United States +115 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions